Suppr超能文献

更新的 ESPGHAN/NASPGHAN 儿童和青少年幽门螺杆菌感染管理指南(2023 年)。

Updated joint ESPGHAN/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023).

机构信息

Faculty of Medicine, Children's Hospital in Ljubljana, University of Ljubljana, Ljubljana, Slovenia.

Division of Gastroenterology Hepatology and Nutrition, SickKids, University of Toronto, Toronto, Ontario, Canada.

出版信息

J Pediatr Gastroenterol Nutr. 2024 Sep;79(3):758-785. doi: 10.1002/jpn3.12314. Epub 2024 Aug 15.

Abstract

BACKGROUND

Evolving epidemiological data and increasing antibiotic resistance mandate an update of the European and North American Societies of Pediatric Gastroenterology, Hepatology and Nutrition guidelines.

METHODS

Certainty of evidence and strength of recommendations were rated by experts according to the Grading of Recommendation Assessment, Development, and Evaluation approach. PICO (patient population, intervention, comparator, and outcome) questions were developed and voted on by the group. Recommendations were formulated using the Evidence to Decision framework.

RESULTS

The current literature supports many of the previous recommendations and several new recommendations. Invasive testing with strain antimicrobial susceptibility analysis is recommended for the diagnosis and selection of eradication therapy for H. pylori infection. Molecular methods are acceptable for detection of infection and of antibiotic resistance in gastric biopsy specimens. Reliable, noninvasive tests can be used as a screening method for children with history of gastric cancer in a first-degree relative. When investigating causes of chronic immune thrombocytopenic purpura, testing for H. pylori is no longer recommended. When investigating other diseases such as inflammatory bowel disease, celiac disease, or eosinophilic esophagitis, specific diagnostic biopsies for H. pylori infection are not indicated. However, if H. pylori is an incidental finding, treatment may be considered after discussing the risks and benefits. Treatment should be based on antibiotic antimicrobial susceptibility testing and, if unavailable, regimens containing clarithromycin should be avoided.

CONCLUSIONS

Due to decreasing prevalence of infection, increasing challenges with antibiotic resistance, and emerging evidence regarding complications of infection, clinicians must be aware of these recommended changes to appropriately manage H. pylori infection and its clinical sequelae in children.

摘要

背景

不断变化的流行病学数据和日益增加的抗生素耐药性要求欧洲和北美儿科学会胃肠病学、肝病学和营养学会更新指南。

方法

根据推荐评估、制定和评估方法,专家对证据的确定性和建议的强度进行了评估。通过小组投票制定了包含患者人群、干预措施、比较和结局的 PICO 问题。使用证据决策框架制定了建议。

结果

目前的文献支持许多以前的建议和一些新的建议。对于幽门螺杆菌感染的诊断和选择根除治疗,建议进行侵袭性检测和菌株抗生素敏感性分析。分子方法可用于胃活检标本中感染和抗生素耐药性的检测。对于有一级亲属胃癌病史的儿童,可以使用可靠的非侵入性检测作为筛查方法。在调查慢性免疫性血小板减少性紫癜的病因时,不再推荐检测幽门螺杆菌。在调查炎症性肠病、乳糜泻或嗜酸性食管炎等其他疾病时,不建议对幽门螺杆菌感染进行特定的诊断性活检。然而,如果幽门螺杆菌是偶然发现的,在讨论了风险和益处后,可以考虑进行治疗。治疗应基于抗生素药敏试验,如果无法进行药敏试验,应避免使用包含克拉霉素的方案。

结论

由于感染的患病率下降、抗生素耐药性的挑战增加以及感染相关并发症的新证据,临床医生必须了解这些推荐的变化,以便适当地管理儿童的幽门螺杆菌感染及其临床后果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验